Prosight Management LP Boosts DexCom Stake by 178.9%

Institutional investor now owns 195,217 shares of medical device company

Mar. 14, 2026 at 11:08am

Got story updates? Submit your updates here. ›

Prosight Management LP, an institutional investor, increased its holdings in DexCom, Inc. (NASDAQ:DXCM) by 178.9% in the third quarter, according to the company's latest SEC filing. Prosight Management LP now owns 195,217 shares of the medical device company's stock, making it the 13th largest position in its portfolio.

Why it matters

DexCom's continuous glucose monitoring (CGM) systems are an important tool for diabetes management, and the company's growth has attracted significant investor interest. Prosight Management's increased stake suggests the firm sees further upside potential in DexCom's stock.

The details

According to the filing, Prosight Management LP added 125,217 shares of DexCom during the third quarter, bringing its total holdings to 195,217 shares. This represents a 178.9% increase in the firm's position. DexCom makes up 3.1% of Prosight Management's portfolio, making it the 13th largest holding.

  • Prosight Management LP increased its DexCom holdings in the third quarter of 2026.

The players

Prosight Management LP

An institutional investor that has increased its stake in medical device company DexCom, Inc.

DexCom, Inc.

A medical device company that develops and manufactures continuous glucose monitoring (CGM) systems for people with diabetes.

Got photos? Submit your photos here. ›

The takeaway

Prosight Management's increased investment in DexCom suggests the firm sees strong growth potential in the medical device company's continuous glucose monitoring technology, which is an important tool for diabetes management.